by St Vincent’s Institute of Medical Research Credit: CC0 Public Domain Researchers at St Vincent’s Institute of Medical Research (SVI) in Melbourne have shown that a commonly prescribed rheumatoid arthritis drug can suppress the progression of type 1 diabetes. The world-first human trial, published in the New England Journal of Medicine and led by SVI’s Professor...
By Michael Irving February 05, 2023 Scientists have used an existing arthritis drug to rejuvenate the blood stem cells of elderly mice Depositphotos In what sounds like dystopian sci-fi, researchers have recently shown that infusions of youthful blood can improve the health of older people. A new study has found that an existing arthritis drug can effectively...
By Nick Lavars October 17, 2022 An approved arthritis drug has shown promise in tackling diabetes and obesity in early mouse studies Depositphotos Scientists studying the activity of a drug used to treat rheumatoid arthritis have discovered it has some surprising functions, some of which may be useful when it comes to countering diabetes. The...
Credit: Unsplash/CC0 Public Domain When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was “on hold” while the pharmacist checked she wasn’t going to use it to induce an abortion. “He said, ‘Well I have to verify if you’re on any contraceptives to...
by Patrick Galey The Britain-based RECOVERY research program investigating COVID-19 treatments said their study could have a significant effect on hospital survival rates during the pandemic The arthritis drug tocilizumab reduces the risk of critically ill patients dying of COVID-19, according to results of a study on Thursday which experts welcomed as an “exciting” development....
AUTHOR Ben Fidler@BentheFidler PUBLISHED Feb. 11, 2021 Dive Brief: An anti-inflammatory drug from Roche cut the risk of death in patients hospitalized with severe COVID-19, investigators in a massive British trial known as RECOVERY reported Thursday, a definitive finding that could change how patients with the disease are treated. Treatment with the drug, which Roche sells as...
By REUTERS and NATALIE RAHHAL US HEALTH EDITOR PUBLISHED: 12:39 EDT, 8 October 2020 Giving coronavirus patients an arthritis drug, on top of the antiviral, remdesivir, reduces their odds of dying by 35 percent, the drug’s maker, Eli Lilly announced Thursday. The National Institutes of Health (NIH) sponsored study found that the combination worked best for patients sick...
by Lancet The first study to report use of the rheumatoid arthritis drug anakinra to treat COVID-19 patients found that high-dose anakinra was safe and was associated with respiratory improvements and reduced signs of cytokine storm in 72% (21/29) of patients, according to results from patients studied for 21 days (enrolled from 17 to 27...
by Peter MacCallum Cancer Centre Researchers from Peter Mac have discovered an innovative way to dampen severe inflammation in mice, uncovering a potential new therapeutic approach for inflammatory and autoimmune conditions such as arthritis, psoriasis and liver disease, as well as some cancers. The research, co-led by Prof Mark Dawson’s laboratory, in collaboration with scientists...
CREDIT: VICTORIA WICKENHEISSER Bethesda, MD – Although today’s rheumatoid arthritis treatments can reduce symptoms, they often come with serious side effects. Results from a new mouse study suggest that a new light-activated drug delivery method helps confine treatments to the joints, which could reduce whole-body side effects. In the U.S., 1.3 million people are currently...
